Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caelyx cardiac effects study in elderly breast cancer patients
2005-002995-13Phase 3Completed
- Sponsor
- UZ Leuven
- Start
- Dec 2005
- Modality
- Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pegylated liposomal doxorubicin and cyclophosphamide in breast cancer, sponsored by UZ Leuven. Started Dec 2005; status: completed.
02
Drugs
pegylated liposomal doxorubicincyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-002995-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002995-13.